Detalles de la búsqueda
1.
Diagnostic Performance of 99mTc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with 18F-PSMA-1007 PET/CT.
Cancers (Basel)
; 15(24)2023 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38136369
2.
Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation.
Diagnostics (Basel)
; 12(6)2022 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35741197
3.
Head-to-Head Comparison of 68Ga-PSMA-11 and 131I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent.
Front Endocrinol (Lausanne)
; 12: 794759, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35002972
4.
Response Assessment of 68Ga-DOTA-E-[c(RGDfK)]2 PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel.
J Nucl Med
; 59(3): 403-409, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28818987
5.
Use of PET/CT as a diagnostic tool in various clinical scenarios related to systemic lupus erythematosus
Rev. colomb. reumatol
; 29(4)oct.-dic. 2022.
Artículo
en Inglés
| LILACS | ID: biblio-1536203
6.
68Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer.
BJR Case Rep
; 3(3): 20160136, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-30363270
Resultados
1 -
6
de 6
1
Próxima >
>>